Capital Goods Healthcare Sector

Zentek

Market Cap: CA$232.6m

Engages in the research and development of graphene and related nanomaterials in Canada.

Tiziana Life Sciences

Market Cap: US$167.2m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

AFT Pharmaceuticals

Market Cap: NZ$283.1m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

LENSAR

Market Cap: US$164.9m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

Liminatus Pharma

Market Cap: US$163.9m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

Wellgistics Health

Market Cap: US$163.9m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

TuHURA Biosciences

Market Cap: US$162.5m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Journey Medical

Market Cap: US$159.0m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Atlantic International

Market Cap: US$158.5m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

Diaceutics

Market Cap: UK£117.5m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

EKF Diagnostics Holdings

Market Cap: UK£117.3m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

hVIVO

Market Cap: UK£117.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Avacta Group

Market Cap: UK£116.0m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Joint

Market Cap: US$155.2m

Operates and franchises chiropractic clinics in the United States.

Race Oncology

Market Cap: AU$241.5m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

Korro Bio

Market Cap: US$151.9m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Vireo Growth

Market Cap: CA$209.4m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Profound Medical

Market Cap: CA$209.2m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

Prime Medicine

Market Cap: US$150.2m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Inhibikase Therapeutics

Market Cap: US$147.9m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Cybin

Market Cap: US$147.5m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

BioAge Labs

Market Cap: US$147.3m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Aclaris Therapeutics

Market Cap: US$146.2m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Pro-Dex

Market Cap: US$145.3m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Fate Therapeutics

Market Cap: US$143.3m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Cogstate

Market Cap: AU$221.9m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

Aldeyra Therapeutics

Market Cap: US$141.4m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

EUDA Health Holdings

Market Cap: US$141.2m

Operates as a healthcare specialty company.

TerrAscend

Market Cap: CA$192.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$192.2m

A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

NeOnc Technologies Holdings

Market Cap: US$137.9m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Rapid Micro Biosystems

Market Cap: US$137.9m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Scancell Holdings

Market Cap: UK£102.7m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

DocGo

Market Cap: US$137.8m

Provides mobile health and medical transportation services in the United States and the United Kingdom.